Adcon-L
From Wikipedia, the free encyclopedia
Adcon-L is a pharmaceutical gel designed to reduce the incidence and severity of scarring in back operations. It consists of a combination of marginally water-soluble artificial sugars, and is re-absorbed into the body within several months of application. This gel was marketed in the United States by Gliatech, approved by the FDA in 1997, and eventually sold to Wright Medical Technologies in result of Gliatech going bankrupt.[1]